Lexpos News

Pharmacy teams are reminded that a number of BD and NovoFine hypodermic insulin pen needles have been deleted from Part IX of the September 2026 Drug Tariff. Any NHS prescriptions for the appliances listed below, where prescribed by brand, would be disallowed by the NHS Business Services Authority (NHSBSA) if dispensed from 1 September 2026: [...]

The post Reminder: BD and Novofine pen needles deleted from September 2026 Drug Tariff appeared first on Community Pharmacy England.

Community pharmacies received strong cross-party backing in Parliament this week, with MPs warning that the Government’s ambitions for more care in the community cannot be delivered unless pharmacy funding is put on a sustainable footing. Yesterday’s Westminster Hall debate, sponsored by Leicester East MP Shivani Raja, focused on Government funding for local pharmacies and the [...]

The post MPs call for sustainable funding for local pharmacies appeared first on Community Pharmacy England.

NHS England has today announced quicker treatment of migraines, acne, scabies, ear infections and rhinitis through the expansion of the Pharmacy First service (see NHS England press release). This has been covered by some media outlets (including BBC News and LBC News) and the official press release includes a comment from Community Pharmacy England: Janet [...]

The post Pharmacies to offer treatment for migraines, acne and 3 other common conditions appeared first on Community Pharmacy England.

In a media release issued today, DHSC and NHS England have formally announced the final choice of the five new prescribing clinical pathways which will be added to the Pharmacy First service this autumn. They are: Acute otitis externa – for adults aged 18 years and over Seasonal allergic rhinitis – for children aged 4-11 [...]

The post NHS England announce the new Pharmacy First prescribing pathways appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Lansoprazole 15mg and 30mg orodispersible tablets. MSN/2026/044 Tier 2 – medium impact Date of issue: 7 September 2026 Lansoprazole 15mg and 30mg orodispersible tablets are in limited supply until early January 2027. Lansoprazole 15mg and 30mg gastro-resistant capsules remain available [...]

The post Medicine Supply Notification: Lansoprazole 15mg and 30mg orodispersible tablets appeared first on Community Pharmacy England.